Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Canadian journal of psychiatry. Revue canadienne de psychiatrie

• Publication date

  2016-08-02

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/0706743716659061PMID 27486152PMCID PMC4994787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort

  2016cited by this paper
• Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial

  2015cited by this paper
• Meta-analysis as evidence: building a better pyramid.

  2014cited by this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

  2013cited by this paper
• Demystifying trial networks and network meta-analysis

  2013cited by this paper
• [GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables].

  2012cited by this paper
• A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME].

  2012cited by this paper
• The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Conditions

  2012cited by this paper
• GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.

  2011cited by this paper
• CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials

  2010cited by this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction.

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy

  2005cited by this paper

• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 International Guidelines for the Management of Patients with Obsessive-Compulsive Disorder

  2026cites this paper
• Urgency to treat and early optimized treatment in major depressive disorder: consequences of delayed treatment, barriers to implementation, and practical strategies for clinicians

  2025cites this paper
• Task-sharing and telemedicine delivery of psychotherapy to treat perinatal depression: a pragmatic, noninferiority randomized trial

  2025cites this paper
• Current Progress in Targeted Pharmacotherapy to Treat Symptoms of Major Depressive Disorder: Moving From Broad-Spectrum Treatments to Precision Psychiatry.

  2025cites this paper
• Role of baseline resting-state functional connectivity of the nucleus accumbens subregions in antidepressant treatment in major depressive disorder

  2025cites this paper
• Effectiveness of pharmacological and non-pharmacological interventions for treatment-resistant depression in older patients: a systematic review and meta-analysis

  2025cites this paper
• Anhedonia and PTSD symptom severity profiles differentially influence physical activity volume in trauma-exposed adults

  2025cites this paper
• Decoding Depression: Insights into Molecular Biomarkers and Neuroimaging of Depression

  2025cites this paper
• Suffering in silence: Accessing mental health care and repetitive transcranial magnetic stimulation (rTMS) for peripartum depression - A qualitative study

  2025cites this paper
• Violet light photobiomodulation therapy for depression: A double-blind randomized crossover trial.

  2025cites this paper
• BioClock—optimizing Bright Light Therapy for adults with depression: a study protocol for a multicenter randomized clinical trial on treatment strategies, response predictors, and chronobiological and neurobiological mechanisms

  2025cites this paper
• Dose-response effects of aerobic exercise on reducing depression in patients with chronic illness and comorbid depression: a systematic review and meta-analysis

  2025cites this paper
• The augmentative efficacy of second-generation anti-psychotics (SGA) to anti-depressants in treating treatment-resistant depression: a network meta-regression analysis

  2025cites this paper
• Serum levels of D-cycloserine predict antidepressant effects in pharmacologically enhanced intermittent theta-burst stimulation.

  2025cites this paper
• Heart Rate Modulation and Clinical Improvement in Major Depression: A Randomized Clinical Trial with Accelerated Intermittent Theta Burst Stimulation

  2025cites this paper
• Longitudinal Associations of Electroconvulsive Therapy with All-cause Mortality and Suicide Deaths in Depression and Other Psychiatric Disorders: A Systematic Review and Meta-Analysis

  2025cites this paper
• Key informant perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care in Ontario, Canada: a qualitative description study

  2025cites this paper
• Clinical Guidelines on Frailty

  2025cites this paper
• Korean Medication Algorithm Project for Depressive Disorder 2025 (II): The Subtypes of Depression

  2025cites this paper
• Complex associations between anxiety, depression, and resilience in a college student sample: a network analysis

  2025cites this paper
• Transdiagnostic internet cognitive behavioural therapy for anxiety and depressive symptoms in postnatal women: protocol of a randomized controlled trial

  2025cites this paper
• Increased odds of metabolic syndrome among adults with depressive symptoms or antidepressant use

  2025cites this paper
• Chronic kidney disease is associated with incident depression requiring treatment: a retrospective cohort study

  2025cites this paper
• Psychotherapy training in psychiatry: a systematic review on the early career psychiatrists’ interests and opportunities

  2025cites this paper
• Impact of Emotional Blunting on Patient Social Function and Depressive Symptoms: A Post Hoc Analysis of a Web-Based Survey in Japanese Patients with Major Depressive Disorder

  2025cites this paper
• Combining theory and usability testing to inform optimization and implementation of an online primary care depression management tool

  2025cites this paper
• Vortioxetine in the routine management of major depressive disorder: an analysis of European automated healthcare databases

  2025cites this paper
• Quality of cognitive-behavioural therapy in routine psychiatric care: therapist adherence and competence, and patient outcomes for depression and anxiety disorders

  2024cites this paper
• Efficacy of vortioxetine versus desvenlafaxine in the treatment of functional impairment in patients with major depressive disorder: Results from the multinational VIVRE study

  2024cites this paper
• Real-world effects of antidepressants for depressive disorder in primary care: population-based cohort study

  2024cites this paper
• Acupuncture and Escitalopram for Treating Major Depression Clinical Study (AE-TMDCS): protocol for a factorial randomised controlled trial

  2024cites this paper
• Association between 24-hour movement behavior and depression in college students: A compositional data analysis.

  2024cites this paper
• The state of implementation science in major depressive disorder: A narrative review.

  2024cites this paper
• Adherence to clinical practice guidelines for using electroconvulsive therapy in elderly depressive patients

  2024cites this paper
• Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients—a randomized rater-blinded trial

  2024cites this paper
• Exposure to psychotropic drugs and breast cancer risk in patients with bipolar disorder and major depressive disorder: a nested case–control study

  2024cites this paper
• Long-term neuropsychiatric complications of aneurysmal subarachnoid hemorrhage: a narrative review

  2024cites this paper
• Comparison of the Patient Health Questionnaire-9 and Quick Inventory of Depressive Symptomatology-Self Report in assessing the antidepressant effects of Transcranial Magnetic Stimulation: Sensitivity to change

  2024cites this paper
• Psychopharmacologic Laziness

  2024cites this paper
• The effect of traditional Chinese medicine on psychological conditions among elderly patients with cancer: a scoping review

  2024cites this paper
• Exploring Therapeutic Potential: A Comprehensive Review of Novel Treatment Targets in Psychotic Depression

  2024influential citation
• Comparison of the Efficacy Between Standard Measurement-Base Care (MBC) and Enhanced MBC for Major Depressive Disorder: A Pilot Study

  2024cites this paper
• Predicting quetiapine dose in patients with depression using machine learning techniques based on real-world evidence

  2024influential citation
• Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression

  2024influential citation
• Adjunctive duration-doubled transcranial direct current stimulation for the treatment of depressive patients with suicidal ideation: study protocol for a double-blind, randomized, sham-controlled trial

  2024cites this paper
• Electroconvulsive therapy research in BRICS and G7 countries: a bibliometric analysis from 2005 to 2024

  2024cites this paper
• Omega-3 PUFAs’ efficacy in the therapy of coronary artery disease combined with anxiety or depression: a meta-analysis

  2024cites this paper
• Suspected agomelatine-induced tongue temperature perception abnormality: a case report.

  2024cites this paper
• Does Baseline Cognitive Function Predict the Reduction Rate in HDRS-17 Total Scores in First-Episode, Drug-Naïve Patients with Major Depressive Disorder?

  2024cites this paper
• What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review

  2024cites this paper
• Different dosage regimens of zuranolone in the treatment of major depressive disorder: A meta-analysis of randomized controlled trials.

  2024cites this paper
• Digital Tools to Facilitate the Detection and Treatment of Bipolar Disorder: Key Developments and Future Directions

  2024cites this paper
• Adjunctive cariprazine for major depressive disorder: a systematic review and meta-analysis

  2024cites this paper
• Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study

  2024cites this paper
• Gender differences in obstructive sleep apnea with comorbid treatment-resistant depression

  2023cites this paper
• Optimization Strategies of Transcranial Magnetic Stimulation in Major Depressive Disorder

  2023influential citation
• Major depressive disorder

  2023cites this paper
• Costs of major depression covered / not covered in British Columbia, Canada

  2023cites this paper
• Prescription réfléchie pour les patients souffrant d’une dépression difficile à traiter

  2023cites this paper
• The value of a model to consider the cost-effectiveness of interventions for the treatment of major depressive disorder in Canada

  2023cites this paper
• Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries

  2023cites this paper
• Sequenced treatment alternatives to relieve adolescent depression (STAR-AD): a multicentre open-label randomized controlled trial protocol

  2023cites this paper
• Telehealth Care for Perinatal Depression in Immigrant and Refugee Women: A Scoping Review

  2023cites this paper
• Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders

  2023cites this paper
• Gender differences in transdiagnostic domains and function of adults measured by DSM-5 assessment scales at the first clinical visit: a cohort study

  2023cites this paper
• The effect of deep repetitive transcranial magnetic stimulation with an H1 coil on hopelessness in patients with major depressive disorder: A randomized controlled trial

  2023cites this paper
• Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials

  2023cites this paper
• Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study

  2023cites this paper
• Vagus and External Trigeminal Nerve Stimulation

  2023cites this paper
• Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence

  2023cites this paper
• Assessing the Feasibility and Acceptability of Pre- and Postnatal Mindfulness-based Programs with Mothers Experiencing Low Income

  2023cites this paper
• História da implantação da eletroconvulsoterapia no Hospital Geral Público de Palmas

  2023cites this paper
• Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis

  2023cites this paper
• Physical exercise and major depressive disorder in adults: systematic review and meta-analysis

  2023cites this paper
• Prevalence and risk factors of anxiety and depression in adult patients with epilepsy: a multicenter survey-based study

  2023cites this paper
• A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)

  2023cites this paper
• Effect of fluvoxamine on plasma interleukin-6 in patients with major depressive disorder: a prospective follow-up study

  2023cites this paper
• Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report

  2023cites this paper
• Use of Serum Biomarkers to Aid Antidepressant Selection in Depressive Patients

  2023cites this paper
• An electric field modeling study with meta-analysis to understand the antidepressant effects of transcranial direct current stimulation (tDCS)

  2023cites this paper
• Deep Brain Stimulation Surgery Programs in Canada

  2023cites this paper
• Nutritional Status in Adults with Disabilities Secondary to Cardiovascular Diseases in a Colombian Municipality A Cross-Sectional Study

  2023cites this paper
• Evaluation of High-Frequency Repetitive Transcranial Magnetic Stimulation Role in improving Motor and Non-motor Manifestations of Parkinson’s Disease in Minia University Hospital

  2023cites this paper
• A Review of Therapeutics for Treatment-Resistant Depression in the Older Adult

  2023cites this paper
• The efficacy and tolerability of inhaled nitrous oxide in major depressive disorder: a systematic review and meta-analysis

  2023cites this paper
• Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder

  2023cites this paper
• Vortioxetine usage in an elderly patient with major depressive disorder and accompanied by multiple physical conditions: A case report

  2023cites this paper
• Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

  2023cites this paper
• Preventive care recommendations to promote health equity

  2023cites this paper
• Noninvasive Vagal Nerve Stimulation for Opioid Use Disorder.

  2023cites this paper
• Comparative efficacy and safety of 4 atypical antipsychotics augmentation treatment for major depressive disorder in adults: A systematic review and network meta-analysis

  2023cites this paper
• Aripiprazole, a Novel Option in the Management of Restless Legs Syndrome (RLS) Patients with Augmentation and/or Severe RLS Symptoms: A Report of 4 Cases

  2023cites this paper
• Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis

  2023cites this paper
• Respuesta inadecuada al tratamiento antidepresivo; recomendaciones de expertos

  2023cites this paper
• Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study

  2023cites this paper
• Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial

  2023cites this paper
• Case report: Treatment-resistant depression, multiple trauma exposure and suicidality in an adolescent female with previously undiagnosed Autism Spectrum Disorder

  2023cites this paper
• How Impulsivity is Associated with Adolescent Depression: The Role of Substance Use, Gender and Social Support

  2023cites this paper
• Accelerated Repetitive Transcranial Magnetic Stimulation to Treat Major Depression: The Past, Present, and Future

  2023cites this paper
• Pharmacological Management of Borderline Personality Disorder and Common Comorbidities

  2023cites this paper